Zobrazeno 1 - 10
of 391
pro vyhledávání: '"Anna M Czarnecka"'
Autor:
Piotr Dunaj, Ewa Żukowska, Anna M. Czarnecka, Maria Krotewicz, Aneta Borkowska, Paulina Chmiel, Tomasz Świtaj, Piotr Rutkowski
Publikováno v:
Oncology Reviews, Vol 18 (2024)
Sarcomas are a rare type of malignancy with limited treatment options so far. This analysis aimed to describe the impact of lymphadenectomy on treating sarcoma patients. Sarcomas characterized by lymphatic spread are rare. For this reason, lymphadene
Externí odkaz:
https://doaj.org/article/c58f77e242924007858af5a670184081
Autor:
Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz, Anna M. Czarnecka
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 778-800 (2024)
Molecular biology studies of uveal melanoma have resulted in the development of novel immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion protein. More biomarkers are currently being studied. As a result, combine
Externí odkaz:
https://doaj.org/article/960539c0f6e54130a155e5bda2dce710
Autor:
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M. Czarnecka, Piotr Rutkowski
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 307-323 (2024)
Soft tissue sarcomas (STS) originating from connective tissue rarely affect the lymph nodes. However, involvement of lymph nodes in STS is an important aspect of prognosis and treatment. Currently, there is no consensus on the diagnosis and managemen
Externí odkaz:
https://doaj.org/article/31600efdc8274a86803e7cc96918616e
Autor:
Piotr J. Błoński, Anna M. Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, Piotr Rutkowski
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 669 (2024)
Neoadjuvant systemic therapy is emerging as the best medical practice in patients with resectable stage III melanoma. As different regimens are expected to become available in this approach, the improved optimization of treatment strategies is requir
Externí odkaz:
https://doaj.org/article/f0064498af39477b99261bc91bf84ded
Autor:
Joanna Radzikowska, Anna M. Czarnecka, Teresa Klepacka, Magdalena Rychłowska-Pruszyńska, Anna Raciborska, Bożenna Dembowska-Bagińska, Maciej Pronicki, Andrzej Kukwa, Wojciech Fendler, Urszula Smyczyńska, Wojciech Kukwa, Antoni Krzeski
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1895 (2022)
(1) Background: The aim of the present study was to assess the cancer stem cell (CSC) markers CD24, CD44, CD133, and ALDH1A1 in rhabdomyosarcoma (RMS) in children and to define their prognostic role in this group of patients. (2) Methods: The study m
Externí odkaz:
https://doaj.org/article/037038de60b74c25bced0d00718b4174
Autor:
Klaudia Łakomska, Kamil Tkacz, Marcin Kleibert, Anna M. Czarnecka, Piotr Rutkowski, Wojciech Zgliczyński, Beata Mrozikewicz-Rakowska
Publikováno v:
Medical Research Journal. 1:84-88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cbf4ee1616542379e215998469a6e37
https://doi.org/10.5603/mrj.a2023.0010
https://doi.org/10.5603/mrj.a2023.0010
Autor:
Karolina Piejko, Bożena Cybulska-Stopa, Marcin Ziętek, Robert Dziura, Łukasz Galus, Natasza Kempa-Kamińska, Barbara Ziółkowska, Ewa Rutkowska, Tomasz Kopciński, Tomasz Kubiatowski, Wiesław Bal, Rafał Suwiński, Jacek Mackiewicz, Grażyna Kamińska-Winciorek, Anna M. Czarnecka, Piotr Rutkowski
Publikováno v:
Targeted Oncology. 18:235-245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d032dbd9e59424f818ea4e8259bfdaf3
https://doi.org/10.1007/s11523-023-00954-w
https://doi.org/10.1007/s11523-023-00954-w
Autor:
Paweł Sobczuk, Anna Brodziak, Mohammed Imran Khan, Stuti Chhabra, Michał Fiedorowicz, Marlena Wełniak-Kamińska, Kamil Synoradzki, Ewa Bartnik, Agnieszka Cudnoch-Jędrzejewska, Anna M. Czarnecka
Publikováno v:
Translational Oncology, Vol 13, Iss 3, Pp - (2020)
The increase in the life expectancy of patients with renal cell carcinoma (RCC) in the last decade is due to changes that have occurred in the area of preclinical studies. Understanding cancer pathophysiology and the emergence of new therapeutic opti
Externí odkaz:
https://doaj.org/article/7f27cf15af5d4629acb2e02a1955a988
Autor:
Mohammed I. Khan, Anna A. Sobocińska, Klaudia K. Brodaczewska, Katarzyna Zielniok, Malgorzata Gajewska, Claudine Kieda, Anna M. Czarnecka, Cezary Szczylik
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-17 (2018)
Abstract Background The anti-tumor properties of cannabinoids have been investigated in many in vitro and in vivo studies. Many of these anti-tumor effects are mediated via cannabinoid receptor types 1 and 2 (CB1 and CB2), comprising the endocannabin
Externí odkaz:
https://doaj.org/article/6c8f1bf7ef424dfdb76e679c586f213f
Autor:
Piotr Rutkowski, Piotr J. Wysocki, Katarzyna Kozak, Anna Nasierowska-Guttmejer, Arkadiusz Jeziorski, Wojciech M. Wysocki, Ewa Kalinka, Tomasz Świtaj, Grażyna Kamińska-Winciorek, Anna M. Czarnecka, Hanna Koseła-Paterczyk, Bożena Cybulska-Stopa, Piotr Wiśniewski, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Marek Ziobro, Jacek Fijuth, Andrzej Kawecki, Andrzej Tysarowski, Bożena Romanowska-Dixon, Anna Markiewicz, Marek Dedecjus, Tomasz Kubiatowski, Kamil Dolecki, Hanna Tchórzewska-Korba, Lidia Rudnicka, Witold Owczarek, Maciej Krzakowski
Publikováno v:
Oncology in Clinical Practice. 18:357-392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4497480ec5ee74da1a6fb9ac31fa9c4
https://doi.org/10.5603/ocp.2021.0042
https://doi.org/10.5603/ocp.2021.0042